Health

Sanofi’s Tzield Approved in the US as the First Disease-Modifying Therapy for Patients Recently Diagnosed with Stage 3 Type 1 Diabetes

DailyTrendDailyTrend
Jun 18, 2026 - 17:00
 0  0
Paris, June 13, 2026. The US Food and Drug Administration (FDA) has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous (own) insulin production in children aged eight to 17 years recently diagnosed with...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication

Accolade Pacemaker Devices by Boston Scientific and Pot...

DailyTrend Jun 18, 2026  0  0

New Plan Scales Back C.D.C.’s Work on Diseases Abroad

New Plan Scales Back C.D.C.’s Work on Diseases Abroad

DailyTrend Jun 18, 2026  0  0

Manifold Recall: Medline Removes Namic Star Off Handle Manifolds 

Manifold Recall: Medline Removes Namic Star Off Handle ...

DailyTrend May 28, 2026  0  0

The Pain of Caring for a Parent Who Abused You

The Pain of Caring for a Parent Who Abused You

DailyTrend Jun 18, 2026  0  0

Anesthesia Machine Correction: Draeger, Inc. Issues Correction for Atlan A350 and A350XL Anesthesia Workstations

Anesthesia Machine Correction: Draeger, Inc. Issues Cor...

DailyTrend Jun 18, 2026  0  0

Beekeeper’s Naturals Issues Voluntary Nationwide Recall of Beekeeper’s Naturals Saline Nasal Spray Sold Through Amazon Due to Microbial Contamination

Beekeeper’s Naturals Issues Voluntary Nationwide Recall...

DailyTrend Jun 18, 2026  0  0